Article: [Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma: a prospective phaseⅡstudy].
2024 Volume 59, Issue 4, Page(s) 321–328
Abstract: Objective: ...
Abstract | Objective: |
---|---|
MeSH term(s) | Male ; Female ; Humans ; Aged ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Platinum ; Prospective Studies ; Paclitaxel/therapeutic use ; Head and Neck Neoplasms/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Albumins ; Antibodies, Monoclonal, Humanized |
Chemical Substances | 130-nm albumin-bound paclitaxel ; pembrolizumab (DPT0O3T46P) ; Platinum (49DFR088MY) ; Paclitaxel (P88XT4IS4D) ; Albumins ; Antibodies, Monoclonal, Humanized |
Language | Chinese |
Publishing date | 2024-04-08 |
Publishing country | China |
Document type | English Abstract ; Journal Article |
ZDB-ID | 2195655-8 |
ISSN | 1673-0860 |
ISSN | 1673-0860 |
DOI | 10.3760/cma.j.cn115330-20231013-00143 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3733: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.